low-dose freeze-dried recombinant tuberculosis vaccine (AEC/BCO2)
/ Chongqing Zhifei
- LARVOL DELTA
Home
Next
Prev
1 to 8
Of
8
Go to page
1
November 28, 2023
A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
(clinicaltrials.gov)
- P2 | N=200 | Suspended | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Recruiting ➔ Suspended
Trial suspension • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
May 09, 2023
A Phase Ⅱ Clinical Trial of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
(clinicaltrials.gov)
- P2 | N=200 | Recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Trial completion date: Oct 2023 ➔ Dec 2024 | Trial primary completion date: Oct 2022 ➔ Jun 2024
Trial completion date • Trial primary completion date • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
September 06, 2022
A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
(clinicaltrials.gov)
- P1 | N=30 | Completed | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Active, not recruiting ➔ Completed
Trial completion • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis
March 17, 2022
A Phase Ⅱ Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BC02)
(clinicaltrials.gov)
- P2 | N=200 | Recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.
New P2 trial • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis • IFNG
February 22, 2022
A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BCO2)
(clinicaltrials.gov)
- P1 | N=30 | Active, not recruiting | Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | Trial completion date: Aug 2021 ➔ Apr 2022 | Trial primary completion date: Jul 2021 ➔ Feb 2021
Trial completion date • Trial primary completion date • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis • IFNG
May 28, 2021
A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BCO2)
(clinicaltrials.gov)
- P1; N=30; Active, not recruiting; Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.; Trial primary completion date: Dec 2020 ➔ Jul 2021
Clinical • Trial primary completion date • Infectious Disease • Pulmonary Disease • Respiratory Diseases • Tuberculosis • IFNG
September 29, 2020
A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BCO2)
(clinicaltrials.gov)
- P1; N=30; Active, not recruiting; Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Infectious Disease • Tuberculosis
June 24, 2020
A Phase Ib Study of the Recombinant Mycobacterium Tuberculosis Vaccine Freeze-dried (AEC/BCO2)
(clinicaltrials.gov)
- P1; N=30; Recruiting; Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.; Not yet recruiting ➔ Recruiting
Clinical • Enrollment open • Infectious Disease • Tuberculosis
1 to 8
Of
8
Go to page
1